Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-23-000150
Filing Date
2023-02-21
Accepted
2023-02-21 16:51:26
Documents
64
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q amgreat20221231_10q.htm   iXBRL 10-Q 931498
2 EXHIBIT 31.1 ex_478376.htm EX-31.1 8319
3 EXHIBIT 32.1 ex_478377.htm EX-32.1 4523
  Complete submission text file 0001185185-23-000150.txt   5689975

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aagh-20221231.xsd EX-101.SCH 54819
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aagh-20221231_cal.xml EX-101.CAL 34532
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aagh-20221231_def.xml EX-101.DEF 260813
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE aagh-20221231_lab.xml EX-101.LAB 438287
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aagh-20221231_pre.xml EX-101.PRE 267817
58 EXTRACTED XBRL INSTANCE DOCUMENT amgreat20221231_10q_htm.xml XML 617342
Mailing Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803
Business Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803 (888) 988-1333
America Great Health (Filer) CIK: 0001098009 (see all company filings)

EIN.: 980178621 | State of Incorp.: CA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-27873 | Film No.: 23649023
SIC: 2834 Pharmaceutical Preparations